12D miR HR13_24
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Dbp
|
ENSMUSG00000059824.4 | D site albumin promoter binding protein |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Dbp | mm10_v2_chr7_+_45705088_45705292 | 0.75 | 7.7e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_89322883 | 2.13 |
ENSMUST00000029673.5
|
Efna3
|
ephrin A3 |
chr16_+_7069825 | 2.02 |
ENSMUST00000056416.7
|
Rbfox1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr16_-_63864114 | 2.00 |
ENSMUST00000064405.6
|
Epha3
|
Eph receptor A3 |
chr3_-_26133734 | 1.83 |
ENSMUST00000108308.3
ENSMUST00000075054.4 |
Nlgn1
|
neuroligin 1 |
chr14_+_115042752 | 1.61 |
ENSMUST00000134140.2
|
Mir17hg
|
Mir17 host gene 1 (non-protein coding) |
chr11_+_77930800 | 1.55 |
ENSMUST00000093995.3
ENSMUST00000000646.7 |
Sez6
|
seizure related gene 6 |
chr19_-_53371766 | 1.53 |
ENSMUST00000086887.1
|
Gm10197
|
predicted gene 10197 |
chr14_+_31217850 | 1.29 |
ENSMUST00000090180.2
|
Sema3g
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G |
chr19_-_28911879 | 1.23 |
ENSMUST00000179171.1
|
AC163993.1
|
AC163993.1 |
chr4_+_122996035 | 1.23 |
ENSMUST00000030407.7
|
Mycl
|
v-myc myelocytomatosis viral oncogene homolog, lung carcinoma derived (avian) |
chr18_+_11633276 | 1.19 |
ENSMUST00000115861.2
|
Rbbp8
|
retinoblastoma binding protein 8 |
chr4_+_122995944 | 1.16 |
ENSMUST00000106252.2
|
Mycl
|
v-myc myelocytomatosis viral oncogene homolog, lung carcinoma derived (avian) |
chr8_-_53638945 | 1.11 |
ENSMUST00000047768.4
|
Neil3
|
nei like 3 (E. coli) |
chr2_-_127521358 | 1.08 |
ENSMUST00000028850.8
ENSMUST00000103215.4 |
Kcnip3
|
Kv channel interacting protein 3, calsenilin |
chr7_+_102441685 | 1.03 |
ENSMUST00000033283.9
|
Rrm1
|
ribonucleotide reductase M1 |
chrX_+_169685191 | 1.01 |
ENSMUST00000112104.1
ENSMUST00000112107.1 |
Mid1
|
midline 1 |
chr1_-_192855723 | 1.00 |
ENSMUST00000155579.1
|
Sertad4
|
SERTA domain containing 4 |
chr4_+_28813125 | 0.95 |
ENSMUST00000029964.5
ENSMUST00000080934.4 |
Epha7
|
Eph receptor A7 |
chr14_+_116925291 | 0.92 |
ENSMUST00000078849.4
|
Gpc6
|
glypican 6 |
chr1_+_66386968 | 0.91 |
ENSMUST00000145419.1
|
Map2
|
microtubule-associated protein 2 |
chr3_+_94372794 | 0.89 |
ENSMUST00000029795.3
|
Rorc
|
RAR-related orphan receptor gamma |
chr3_-_108722281 | 0.89 |
ENSMUST00000029482.9
|
Gpsm2
|
G-protein signalling modulator 2 (AGS3-like, C. elegans) |
chr9_+_32224457 | 0.85 |
ENSMUST00000183121.1
|
Arhgap32
|
Rho GTPase activating protein 32 |
chr1_-_183147461 | 0.85 |
ENSMUST00000171366.1
|
Disp1
|
dispatched homolog 1 (Drosophila) |
chr7_-_48881032 | 0.85 |
ENSMUST00000058745.8
|
E2f8
|
E2F transcription factor 8 |
chr14_+_70077375 | 0.84 |
ENSMUST00000035908.1
|
Egr3
|
early growth response 3 |
chr5_+_98854434 | 0.83 |
ENSMUST00000031278.4
|
Bmp3
|
bone morphogenetic protein 3 |
chr4_+_28813152 | 0.82 |
ENSMUST00000108194.2
ENSMUST00000108191.1 |
Epha7
|
Eph receptor A7 |
chr14_+_116925379 | 0.80 |
ENSMUST00000088483.3
|
Gpc6
|
glypican 6 |
chr14_+_116925516 | 0.80 |
ENSMUST00000125435.1
|
Gpc6
|
glypican 6 |
chrX_-_72656135 | 0.79 |
ENSMUST00000055966.6
|
Gabra3
|
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3 |
chr6_+_15185456 | 0.77 |
ENSMUST00000115472.1
ENSMUST00000115474.1 ENSMUST00000031545.7 ENSMUST00000137628.1 |
Foxp2
|
forkhead box P2 |
chr13_-_28953690 | 0.73 |
ENSMUST00000067230.5
|
Sox4
|
SRY-box containing gene 4 |
chr13_+_55464237 | 0.73 |
ENSMUST00000046533.7
|
Prr7
|
proline rich 7 (synaptic) |
chr7_-_127021205 | 0.73 |
ENSMUST00000159916.1
|
Prrt2
|
proline-rich transmembrane protein 2 |
chr6_-_113501818 | 0.68 |
ENSMUST00000101059.1
|
Prrt3
|
proline-rich transmembrane protein 3 |
chr2_-_28916412 | 0.66 |
ENSMUST00000050776.2
ENSMUST00000113849.1 |
Barhl1
|
BarH-like 1 (Drosophila) |
chr19_-_46327121 | 0.66 |
ENSMUST00000041391.4
ENSMUST00000096029.5 |
Psd
|
pleckstrin and Sec7 domain containing |
chr12_-_28623282 | 0.63 |
ENSMUST00000036136.7
|
Colec11
|
collectin sub-family member 11 |
chr1_-_163994767 | 0.63 |
ENSMUST00000097493.3
ENSMUST00000045876.6 |
BC055324
|
cDNA sequence BC055324 |
chr10_-_128891674 | 0.60 |
ENSMUST00000026408.6
|
Gdf11
|
growth differentiation factor 11 |
chr4_+_136143497 | 0.59 |
ENSMUST00000008016.2
|
Id3
|
inhibitor of DNA binding 3 |
chr4_-_87806276 | 0.59 |
ENSMUST00000148059.1
|
Mllt3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
chr15_-_36598019 | 0.56 |
ENSMUST00000155116.1
|
Pabpc1
|
poly(A) binding protein, cytoplasmic 1 |
chr3_+_103832741 | 0.56 |
ENSMUST00000106822.1
|
Bcl2l15
|
BCLl2-like 15 |
chr17_-_35838208 | 0.56 |
ENSMUST00000134978.2
|
Tubb5
|
tubulin, beta 5 class I |
chr9_-_114564315 | 0.55 |
ENSMUST00000111816.2
|
Trim71
|
tripartite motif-containing 71 |
chr16_-_21947536 | 0.54 |
ENSMUST00000023562.7
|
Tmem41a
|
transmembrane protein 41a |
chr9_+_21029373 | 0.53 |
ENSMUST00000001040.5
|
Icam4
|
intercellular adhesion molecule 4, Landsteiner-Wiener blood group |
chr14_-_20496780 | 0.51 |
ENSMUST00000022353.3
|
Mss51
|
MSS51 mitochondrial translational activator |
chr2_+_107290590 | 0.51 |
ENSMUST00000037012.2
|
Kcna4
|
potassium voltage-gated channel, shaker-related subfamily, member 4 |
chrX_+_71050160 | 0.51 |
ENSMUST00000082088.3
ENSMUST00000114629.3 |
Mamld1
|
mastermind-like domain containing 1 |
chr9_-_4796218 | 0.51 |
ENSMUST00000027020.6
ENSMUST00000063508.7 ENSMUST00000163309.1 |
Gria4
|
glutamate receptor, ionotropic, AMPA4 (alpha 4) |
chr12_-_73047179 | 0.50 |
ENSMUST00000050029.7
|
Six1
|
sine oculis-related homeobox 1 |
chr2_+_50066429 | 0.49 |
ENSMUST00000112712.3
ENSMUST00000128451.1 ENSMUST00000053208.7 |
Lypd6
|
LY6/PLAUR domain containing 6 |
chr19_+_45006475 | 0.49 |
ENSMUST00000026227.2
|
Peo1
|
progressive external ophthalmoplegia 1 (human) |
chr17_-_45592262 | 0.48 |
ENSMUST00000164769.1
|
Slc29a1
|
solute carrier family 29 (nucleoside transporters), member 1 |
chr14_+_120275669 | 0.48 |
ENSMUST00000088419.6
ENSMUST00000167459.1 |
Mbnl2
|
muscleblind-like 2 |
chr2_-_40702800 | 0.47 |
ENSMUST00000142546.1
|
Lrp1b
|
low density lipoprotein-related protein 1B (deleted in tumors) |
chr8_-_84773381 | 0.47 |
ENSMUST00000109764.1
|
Nfix
|
nuclear factor I/X |
chr3_+_79884496 | 0.47 |
ENSMUST00000118853.1
|
Fam198b
|
family with sequence similarity 198, member B |
chr2_+_68117713 | 0.47 |
ENSMUST00000112346.2
|
B3galt1
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 |
chr10_+_85386813 | 0.47 |
ENSMUST00000105307.1
ENSMUST00000020231.3 |
Btbd11
|
BTB (POZ) domain containing 11 |
chr11_+_96351632 | 0.47 |
ENSMUST00000100523.5
|
Hoxb2
|
homeobox B2 |
chr5_+_107497718 | 0.47 |
ENSMUST00000112671.2
|
A830010M20Rik
|
RIKEN cDNA A830010M20 gene |
chr8_+_70501116 | 0.47 |
ENSMUST00000127983.1
|
Crlf1
|
cytokine receptor-like factor 1 |
chr5_-_100820929 | 0.46 |
ENSMUST00000117364.1
ENSMUST00000055245.6 |
Fam175a
|
family with sequence similarity 175, member A |
chr17_-_35838259 | 0.46 |
ENSMUST00000001566.8
|
Tubb5
|
tubulin, beta 5 class I |
chrX_-_7671341 | 0.46 |
ENSMUST00000033486.5
|
Plp2
|
proteolipid protein 2 |
chr5_+_107497762 | 0.45 |
ENSMUST00000152474.1
ENSMUST00000060553.7 |
A830010M20Rik
|
RIKEN cDNA A830010M20 gene |
chr2_-_28916668 | 0.45 |
ENSMUST00000113847.1
|
Barhl1
|
BarH-like 1 (Drosophila) |
chr18_-_42579652 | 0.43 |
ENSMUST00000054738.3
|
Gpr151
|
G protein-coupled receptor 151 |
chr1_-_165934900 | 0.43 |
ENSMUST00000069609.5
ENSMUST00000111427.2 ENSMUST00000111426.4 |
Pou2f1
|
POU domain, class 2, transcription factor 1 |
chrX_-_134583114 | 0.43 |
ENSMUST00000113213.1
ENSMUST00000033617.6 |
Btk
|
Bruton agammaglobulinemia tyrosine kinase |
chr9_+_103305156 | 0.43 |
ENSMUST00000035164.3
|
Topbp1
|
topoisomerase (DNA) II binding protein 1 |
chr8_+_45628176 | 0.42 |
ENSMUST00000130850.1
|
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr14_-_102982630 | 0.42 |
ENSMUST00000184744.1
|
KCTD12
|
mmu-mir-5130 |
chr10_+_127421208 | 0.41 |
ENSMUST00000168780.1
|
R3hdm2
|
R3H domain containing 2 |
chr14_-_70524068 | 0.40 |
ENSMUST00000022692.3
|
Sftpc
|
surfactant associated protein C |
chr9_+_53771499 | 0.40 |
ENSMUST00000048670.8
|
Slc35f2
|
solute carrier family 35, member F2 |
chr4_+_109343029 | 0.40 |
ENSMUST00000030281.5
|
Eps15
|
epidermal growth factor receptor pathway substrate 15 |
chr1_-_45503282 | 0.39 |
ENSMUST00000086430.4
|
Col5a2
|
collagen, type V, alpha 2 |
chr9_+_32224246 | 0.39 |
ENSMUST00000168954.2
|
Arhgap32
|
Rho GTPase activating protein 32 |
chr11_+_70432627 | 0.39 |
ENSMUST00000084954.6
ENSMUST00000108568.3 ENSMUST00000079056.2 ENSMUST00000102564.4 ENSMUST00000124943.1 ENSMUST00000150076.1 ENSMUST00000102563.1 |
Arrb2
|
arrestin, beta 2 |
chr1_+_164796723 | 0.39 |
ENSMUST00000027861.4
|
Dpt
|
dermatopontin |
chr11_+_24078173 | 0.39 |
ENSMUST00000109514.1
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr17_+_71204647 | 0.39 |
ENSMUST00000126681.1
|
Lpin2
|
lipin 2 |
chr14_-_54926784 | 0.38 |
ENSMUST00000022813.6
|
Efs
|
embryonal Fyn-associated substrate |
chr3_+_103832562 | 0.37 |
ENSMUST00000062945.5
|
Bcl2l15
|
BCLl2-like 15 |
chr6_-_53820764 | 0.36 |
ENSMUST00000127748.2
|
Tril
|
TLR4 interactor with leucine-rich repeats |
chr12_+_108605757 | 0.36 |
ENSMUST00000109854.2
|
Evl
|
Ena-vasodilator stimulated phosphoprotein |
chr16_+_20733104 | 0.36 |
ENSMUST00000115423.1
ENSMUST00000007171.6 |
Chrd
|
chordin |
chr1_+_34121250 | 0.35 |
ENSMUST00000183006.1
|
Dst
|
dystonin |
chr3_+_103860265 | 0.35 |
ENSMUST00000029433.7
|
Ptpn22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid) |
chr6_+_38918969 | 0.35 |
ENSMUST00000003017.6
|
Tbxas1
|
thromboxane A synthase 1, platelet |
chr5_+_105824511 | 0.35 |
ENSMUST00000055994.3
|
D830014E11Rik
|
RIKEN cDNA D830014E11 gene |
chr16_-_95586585 | 0.34 |
ENSMUST00000077773.6
|
Erg
|
avian erythroblastosis virus E-26 (v-ets) oncogene related |
chr2_+_174327747 | 0.34 |
ENSMUST00000087871.4
|
Gnas
|
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
chr1_+_127306706 | 0.34 |
ENSMUST00000171405.1
|
Mgat5
|
mannoside acetylglucosaminyltransferase 5 |
chr6_-_30390997 | 0.34 |
ENSMUST00000152391.2
ENSMUST00000115184.1 ENSMUST00000080812.7 ENSMUST00000102992.3 |
Zc3hc1
|
zinc finger, C3HC type 1 |
chr3_-_80802789 | 0.34 |
ENSMUST00000107745.1
ENSMUST00000075316.4 |
Gria2
|
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
chr3_+_84925476 | 0.33 |
ENSMUST00000107675.1
|
Fbxw7
|
F-box and WD-40 domain protein 7 |
chr9_+_54764748 | 0.33 |
ENSMUST00000034830.8
|
Crabp1
|
cellular retinoic acid binding protein I |
chr2_-_144527341 | 0.33 |
ENSMUST00000163701.1
ENSMUST00000081982.5 |
Dzank1
|
double zinc ribbon and ankyrin repeat domains 1 |
chr7_-_25072287 | 0.33 |
ENSMUST00000003468.8
|
Grik5
|
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
chr7_-_81566939 | 0.33 |
ENSMUST00000042318.5
|
Fsd2
|
fibronectin type III and SPRY domain containing 2 |
chr3_-_95357156 | 0.32 |
ENSMUST00000107171.3
ENSMUST00000015841.5 ENSMUST00000107170.2 |
Setdb1
|
SET domain, bifurcated 1 |
chr13_+_4049001 | 0.32 |
ENSMUST00000118717.2
|
Akr1c14
|
aldo-keto reductase family 1, member C14 |
chr10_-_51631458 | 0.32 |
ENSMUST00000020062.3
|
Gprc6a
|
G protein-coupled receptor, family C, group 6, member A |
chr11_-_49712674 | 0.32 |
ENSMUST00000020624.6
ENSMUST00000145353.1 |
Cnot6
|
CCR4-NOT transcription complex, subunit 6 |
chr3_+_51559757 | 0.31 |
ENSMUST00000180616.1
|
5031434O11Rik
|
RIKEN cDNA 5031434O11 gene |
chr19_+_11895999 | 0.31 |
ENSMUST00000072784.2
|
Olfr1420
|
olfactory receptor 1420 |
chr4_-_87806296 | 0.31 |
ENSMUST00000126353.1
ENSMUST00000149357.1 |
Mllt3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
chr11_+_50225315 | 0.31 |
ENSMUST00000041725.7
|
Mgat4b
|
mannoside acetylglucosaminyltransferase 4, isoenzyme B |
chr2_+_156196642 | 0.31 |
ENSMUST00000037401.8
|
Phf20
|
PHD finger protein 20 |
chr11_+_58307122 | 0.31 |
ENSMUST00000049353.8
|
Zfp692
|
zinc finger protein 692 |
chr19_-_55241236 | 0.30 |
ENSMUST00000069183.6
|
Gucy2g
|
guanylate cyclase 2g |
chr7_+_35802593 | 0.30 |
ENSMUST00000052454.2
|
E130304I02Rik
|
RIKEN cDNA E130304I02 gene |
chr9_-_79759849 | 0.29 |
ENSMUST00000034881.6
|
Cox7a2
|
cytochrome c oxidase subunit VIIa 2 |
chr14_-_101609033 | 0.29 |
ENSMUST00000161991.1
ENSMUST00000100340.3 |
Tbc1d4
|
TBC1 domain family, member 4 |
chr3_-_50443603 | 0.29 |
ENSMUST00000029297.4
|
Slc7a11
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 |
chr8_+_46739745 | 0.29 |
ENSMUST00000034041.7
|
Irf2
|
interferon regulatory factor 2 |
chr13_-_103764502 | 0.28 |
ENSMUST00000074616.5
|
Srek1
|
splicing regulatory glutamine/lysine-rich protein 1 |
chr13_-_56135629 | 0.28 |
ENSMUST00000016081.6
ENSMUST00000045788.7 |
H2afy
|
H2A histone family, member Y |
chr7_+_89404356 | 0.28 |
ENSMUST00000058755.3
|
Fzd4
|
frizzled homolog 4 (Drosophila) |
chr1_-_170589791 | 0.28 |
ENSMUST00000161966.1
ENSMUST00000160456.1 |
Nos1ap
|
nitric oxide synthase 1 (neuronal) adaptor protein |
chr2_-_148443543 | 0.28 |
ENSMUST00000099269.3
|
Cd93
|
CD93 antigen |
chr6_+_71199827 | 0.28 |
ENSMUST00000067492.7
|
Fabp1
|
fatty acid binding protein 1, liver |
chr11_-_11898044 | 0.27 |
ENSMUST00000066237.3
|
Ddc
|
dopa decarboxylase |
chr3_-_130730375 | 0.27 |
ENSMUST00000079085.6
|
Rpl34
|
ribosomal protein L34 |
chr6_-_94700137 | 0.27 |
ENSMUST00000101126.2
ENSMUST00000032105.4 |
Lrig1
|
leucine-rich repeats and immunoglobulin-like domains 1 |
chr19_-_12765447 | 0.27 |
ENSMUST00000112933.1
|
Cntf
|
ciliary neurotrophic factor |
chrX_+_36795642 | 0.27 |
ENSMUST00000016463.3
|
Slc25a5
|
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 5 |
chr3_+_13946368 | 0.27 |
ENSMUST00000171075.1
ENSMUST00000108372.2 |
Ralyl
|
RALY RNA binding protein-like |
chr4_-_132398199 | 0.27 |
ENSMUST00000136711.1
ENSMUST00000084249.4 |
Phactr4
|
phosphatase and actin regulator 4 |
chr7_+_57591147 | 0.27 |
ENSMUST00000039697.7
|
Gabrb3
|
gamma-aminobutyric acid (GABA) A receptor, subunit beta 3 |
chr8_+_94745590 | 0.26 |
ENSMUST00000034231.3
|
Ccl22
|
chemokine (C-C motif) ligand 22 |
chr11_+_78920787 | 0.26 |
ENSMUST00000018610.6
|
Nos2
|
nitric oxide synthase 2, inducible |
chr7_+_96522342 | 0.26 |
ENSMUST00000129737.1
|
Tenm4
|
teneurin transmembrane protein 4 |
chr11_+_24078022 | 0.25 |
ENSMUST00000000881.6
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr8_-_115707778 | 0.25 |
ENSMUST00000109104.1
|
Maf
|
avian musculoaponeurotic fibrosarcoma (v-maf) AS42 oncogene homolog |
chr19_+_47067721 | 0.25 |
ENSMUST00000026027.5
|
Taf5
|
TAF5 RNA polymerase II, TATA box binding protein (TBP)-associated factor |
chr17_+_50698525 | 0.24 |
ENSMUST00000061681.7
|
Gm7334
|
predicted gene 7334 |
chr10_+_127420867 | 0.24 |
ENSMUST00000064793.6
|
R3hdm2
|
R3H domain containing 2 |
chr17_+_29318850 | 0.24 |
ENSMUST00000114701.2
|
Pi16
|
peptidase inhibitor 16 |
chr3_+_95124476 | 0.23 |
ENSMUST00000131597.1
ENSMUST00000005769.6 ENSMUST00000107227.1 |
Tmod4
|
tropomodulin 4 |
chr11_-_69549108 | 0.23 |
ENSMUST00000108659.1
|
Dnah2
|
dynein, axonemal, heavy chain 2 |
chr7_+_45785331 | 0.23 |
ENSMUST00000120005.1
ENSMUST00000123585.1 |
Lmtk3
|
lemur tyrosine kinase 3 |
chrX_-_57281591 | 0.23 |
ENSMUST00000114735.2
|
Arhgef6
|
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 |
chr8_-_70700070 | 0.23 |
ENSMUST00000116172.1
|
Gm11175
|
predicted gene 11175 |
chr11_+_24078111 | 0.23 |
ENSMUST00000109516.1
|
Bcl11a
|
B cell CLL/lymphoma 11A (zinc finger protein) |
chr13_+_113794505 | 0.22 |
ENSMUST00000091201.6
|
Arl15
|
ADP-ribosylation factor-like 15 |
chr10_-_121311034 | 0.22 |
ENSMUST00000064107.5
|
Tbc1d30
|
TBC1 domain family, member 30 |
chr11_-_11898092 | 0.22 |
ENSMUST00000178704.1
|
Ddc
|
dopa decarboxylase |
chr2_+_18064645 | 0.22 |
ENSMUST00000114680.2
|
Mllt10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 |
chr6_+_39420378 | 0.22 |
ENSMUST00000090237.2
|
Gm10244
|
predicted gene 10244 |
chr10_+_127421124 | 0.21 |
ENSMUST00000170336.1
|
R3hdm2
|
R3H domain containing 2 |
chr15_-_44428303 | 0.21 |
ENSMUST00000038719.6
|
Nudcd1
|
NudC domain containing 1 |
chr15_+_44428073 | 0.21 |
ENSMUST00000060652.3
|
Eny2
|
enhancer of yellow 2 homolog (Drosophila) |
chr17_+_34644805 | 0.21 |
ENSMUST00000174796.1
|
Fkbpl
|
FK506 binding protein-like |
chr3_-_144202300 | 0.21 |
ENSMUST00000121796.1
ENSMUST00000121112.1 |
Lmo4
|
LIM domain only 4 |
chr10_+_90576252 | 0.20 |
ENSMUST00000182427.1
ENSMUST00000182053.1 ENSMUST00000182113.1 |
Anks1b
|
ankyrin repeat and sterile alpha motif domain containing 1B |
chr3_+_18054258 | 0.20 |
ENSMUST00000026120.6
|
Bhlhe22
|
basic helix-loop-helix family, member e22 |
chr17_+_24669730 | 0.20 |
ENSMUST00000047179.5
|
Zfp598
|
zinc finger protein 598 |
chr4_+_99829437 | 0.20 |
ENSMUST00000124547.1
ENSMUST00000106994.1 |
Efcab7
|
EF-hand calcium binding domain 7 |
chr14_+_74735641 | 0.20 |
ENSMUST00000177283.1
|
Esd
|
esterase D/formylglutathione hydrolase |
chr19_+_44493472 | 0.19 |
ENSMUST00000041163.4
|
Wnt8b
|
wingless related MMTV integration site 8b |
chr10_+_87860030 | 0.19 |
ENSMUST00000062862.6
|
Igf1
|
insulin-like growth factor 1 |
chr17_+_29319183 | 0.19 |
ENSMUST00000114699.1
ENSMUST00000155348.1 |
Pi16
|
peptidase inhibitor 16 |
chr7_-_105574324 | 0.19 |
ENSMUST00000081165.7
|
Apbb1
|
amyloid beta (A4) precursor protein-binding, family B, member 1 |
chr3_+_51559973 | 0.19 |
ENSMUST00000180404.1
|
5031434O11Rik
|
RIKEN cDNA 5031434O11 gene |
chr2_+_35691893 | 0.19 |
ENSMUST00000065001.5
|
Dab2ip
|
disabled 2 interacting protein |
chr2_-_148040196 | 0.19 |
ENSMUST00000136555.1
|
9030622O22Rik
|
RIKEN cDNA 9030622O22 gene |
chr18_-_13972617 | 0.18 |
ENSMUST00000025288.7
|
Zfp521
|
zinc finger protein 521 |
chr16_+_33794008 | 0.18 |
ENSMUST00000115044.1
|
Muc13
|
mucin 13, epithelial transmembrane |
chr5_-_51553896 | 0.18 |
ENSMUST00000132734.1
|
Ppargc1a
|
peroxisome proliferative activated receptor, gamma, coactivator 1 alpha |
chr19_-_31664356 | 0.18 |
ENSMUST00000073581.5
|
Prkg1
|
protein kinase, cGMP-dependent, type I |
chr4_-_82850721 | 0.18 |
ENSMUST00000139401.1
|
Zdhhc21
|
zinc finger, DHHC domain containing 21 |
chr2_+_18064564 | 0.18 |
ENSMUST00000114671.1
|
Mllt10
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 |
chr2_+_30078213 | 0.18 |
ENSMUST00000150770.1
|
Pkn3
|
protein kinase N3 |
chrX_+_56894372 | 0.18 |
ENSMUST00000136396.1
|
Gpr112
|
G protein-coupled receptor 112 |
chr3_-_14611221 | 0.17 |
ENSMUST00000108365.2
|
1810022K09Rik
|
RIKEN cDNA 1810022K09 gene |
chr4_+_80910646 | 0.17 |
ENSMUST00000055922.3
|
Lurap1l
|
leucine rich adaptor protein 1-like |
chr5_+_65537209 | 0.17 |
ENSMUST00000142407.1
|
Ube2k
|
ubiquitin-conjugating enzyme E2K |
chr2_+_144527718 | 0.16 |
ENSMUST00000028914.2
ENSMUST00000110017.2 |
Polr3f
|
polymerase (RNA) III (DNA directed) polypeptide F |
chr11_+_3650253 | 0.16 |
ENSMUST00000096441.3
|
Morc2a
|
microrchidia 2A |
chr9_+_72438519 | 0.16 |
ENSMUST00000184604.1
|
Mns1
|
meiosis-specific nuclear structural protein 1 |
chr8_+_69822429 | 0.16 |
ENSMUST00000164890.1
ENSMUST00000034325.4 |
Lpar2
|
lysophosphatidic acid receptor 2 |
chrX_+_74424534 | 0.16 |
ENSMUST00000135165.1
ENSMUST00000114128.1 ENSMUST00000114133.2 ENSMUST00000004330.3 |
Ikbkg
|
inhibitor of kappaB kinase gamma |
chr12_+_7977640 | 0.16 |
ENSMUST00000171271.1
ENSMUST00000037811.6 ENSMUST00000037520.7 |
Apob
|
apolipoprotein B |
chr16_-_34513944 | 0.16 |
ENSMUST00000151491.1
ENSMUST00000114960.2 |
Kalrn
|
kalirin, RhoGEF kinase |
chr10_+_67537861 | 0.16 |
ENSMUST00000048289.7
ENSMUST00000105438.2 ENSMUST00000130933.1 ENSMUST00000146986.1 |
Egr2
|
early growth response 2 |
chr4_-_119538769 | 0.15 |
ENSMUST00000079611.6
|
AA415398
|
expressed sequence AA415398 |
chr3_-_57575760 | 0.15 |
ENSMUST00000029380.7
|
Wwtr1
|
WW domain containing transcription regulator 1 |
chrX_-_155216338 | 0.15 |
ENSMUST00000112551.3
|
Sat1
|
spermidine/spermine N1-acetyl transferase 1 |
chrX_+_106920618 | 0.15 |
ENSMUST00000060576.7
|
Lpar4
|
lysophosphatidic acid receptor 4 |
chr6_-_40585783 | 0.15 |
ENSMUST00000177178.1
ENSMUST00000129948.2 ENSMUST00000101491.4 |
Clec5a
|
C-type lectin domain family 5, member a |
chr17_+_28951950 | 0.15 |
ENSMUST00000153462.1
|
Kctd20
|
potassium channel tetramerisation domain containing 20 |
chr13_+_38036989 | 0.14 |
ENSMUST00000021866.8
|
Riok1
|
RIO kinase 1 (yeast) |
chr6_-_71823805 | 0.14 |
ENSMUST00000065103.2
|
Mrpl35
|
mitochondrial ribosomal protein L35 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.6 | 1.8 | GO:0099543 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) retrograde trans-synaptic signaling(GO:0098917) trans-synaptic signaling by soluble gas(GO:0099543) |
0.5 | 2.1 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.4 | 0.7 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.3 | 0.8 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.3 | 1.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 1.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.2 | 0.9 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.2 | 0.9 | GO:1904800 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) |
0.2 | 2.4 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 0.5 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 0.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.4 | GO:0002343 | peripheral B cell selection(GO:0002343) B cell affinity maturation(GO:0002344) |
0.1 | 0.4 | GO:0071661 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
0.1 | 0.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.6 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.3 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.2 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 1.0 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.4 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.1 | 0.3 | GO:0034093 | negative regulation of histone phosphorylation(GO:0033128) positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.3 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.1 | 0.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) cerebellum vasculature development(GO:0061300) |
0.1 | 0.3 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.1 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.6 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.1 | 0.3 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.1 | 0.4 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 1.7 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 1.7 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.1 | 0.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 0.5 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 0.3 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.1 | 0.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.1 | 0.5 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.3 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 0.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.3 | GO:0032289 | central nervous system myelin formation(GO:0032289) cardiac cell fate specification(GO:0060912) |
0.1 | 0.3 | GO:2000327 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 1.5 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 1.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.0 | 0.2 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.0 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.2 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.0 | 0.3 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.0 | 0.1 | GO:1903406 | regulation of sodium:potassium-exchanging ATPase activity(GO:1903406) |
0.0 | 0.4 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.0 | 0.2 | GO:0021666 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.0 | 0.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.8 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.2 | GO:0097473 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.0 | 0.2 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.0 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.5 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.2 | GO:2000224 | negative regulation of inositol phosphate biosynthetic process(GO:0010920) regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) regulation of testosterone biosynthetic process(GO:2000224) |
0.0 | 0.6 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) |
0.0 | 0.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.5 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.2 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.0 | 0.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.0 | 0.2 | GO:1904075 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.0 | 1.3 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.0 | 0.1 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.0 | 0.7 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 0.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.0 | 0.3 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.1 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.0 | 1.4 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.1 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.3 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.7 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 1.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.1 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.0 | 0.6 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.0 | 0.9 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.0 | 0.1 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.0 | 0.2 | GO:0060137 | maternal process involved in parturition(GO:0060137) behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.0 | 0.5 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.0 | 0.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.0 | 0.1 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.0 | 0.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.0 | 0.1 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.0 | 0.0 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.5 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.9 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 0.2 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.5 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.4 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.0 | 0.1 | GO:0031509 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
0.0 | 0.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.0 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.0 | 0.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) actin filament reorganization(GO:0090527) |
0.0 | 0.1 | GO:0051001 | glycosylceramide catabolic process(GO:0046477) negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 0.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 0.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 0.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 1.0 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.9 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 2.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 0.3 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 0.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.3 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 0.2 | GO:1990032 | parallel fiber(GO:1990032) |
0.0 | 0.9 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.9 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 1.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.0 | 0.4 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.2 | GO:0042567 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.4 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.3 | GO:0098839 | postsynaptic density membrane(GO:0098839) postsynaptic specialization membrane(GO:0099634) |
0.0 | 0.3 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.0 | 3.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 1.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 1.8 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.0 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.2 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 1.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.5 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.0 | 0.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 0.1 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.3 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 1.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.2 | 1.0 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.9 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.6 | GO:0004058 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
0.1 | 0.4 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.1 | 0.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.1 | 0.3 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.3 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.1 | 0.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.3 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.1 | 0.3 | GO:0034617 | nitric-oxide synthase activity(GO:0004517) tetrahydrobiopterin binding(GO:0034617) |
0.1 | 1.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 2.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 1.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 1.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.2 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
0.1 | 0.3 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.1 | 1.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.3 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.1 | 0.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.8 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.0 | 0.3 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 2.1 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.3 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.0 | 0.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.5 | GO:0030955 | potassium ion binding(GO:0030955) |
0.0 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.6 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.0 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.3 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.2 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.3 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.0 | 0.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.5 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.1 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.0 | 0.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 2.8 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.6 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.3 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.2 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 1.6 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 5.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.4 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.5 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.4 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.3 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.2 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.6 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.9 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 1.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 1.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.0 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 1.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 0.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |